FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Drug Compounding Actions Improved Public Health: FDA

FDA says its work implementing the Drug Quality and Security Act has included stepped up inspections at drug compounders that led to corrective action...

Medical Devices

SonaCare Gains Clearance on Updated Sonablate

FDA clears a SonaCare Medical 510(k) for its latest version of Sonablate, a high-intensity focused ultrasound device intended for focused ablation of ...

Human Drugs

Biopharmaceutical Innovation Robust: QuintilesIMS Report

A QuintilesIMS Institute report reviewing 20 years of biopharmaceutical innovation says that the industry is robust and has launched 667 biopharmaceut...

Human Drugs

CDER Planning 101 Guidances This Year

CDER says it will publish 101 new and revised draft guidances in this fiscal year.

Medical Devices

Implantable Infusion Pump Concerns in MR Environment

FDA makes recommendations to reduce the risk of adverse events in patients with implantable infusion pumps undergoing MRI exams.

Human Drugs

FDA Accepts Mylan BLA for Biosimilar Herceptin

FDA accepts a Mylan BLA for a biosimilar version of Genentechs Herceptin.

Human Drugs

Low Professional Engagement Hurts Trial Recruitment: Survey

A Tufts Center for the Study of Drug Development survey shows that lack of healthcare provider engagement in the process is hurting clinical trial rec...

Medical Devices

Bayer Class 1 Recall of PET Infusion System Component

Bayer begins a Class 1 recall of its Medrad Intego PET Infusion System Source Administration Sets due to particulates generated in vials.

Federal Register

Draft Guide on OTC Aspirin-Containing Products

Federal Register Notice: FDA announces the availability of a draft guidance entitled Recommended Statement for Over-the-Counter Aspirin-Containing Dru...

Human Drugs

FDA Priority Review for Merck sBLA for Keytruda

FDA accepts for priority review a Merck supplemental BLA for Keytruda (pembrolizumab), the companys anti-PD-1 therapy, plus chemotherapy (pemetrexed p...